CME/CE Activity Sorter
(Select therapeutic category and activity type of interest and view your sorted activities below)

Your Sorted CME/CE Activities

Number of search result: 24

Talking Hemophilia A:  Integrating Novel Treatments and Enhancing Patient Outcomes

Talking Hemophilia A: Integrating Novel Treatments and Enhancing Patient Outcomes

Lightning Reports™ from ASH 2022 on Low and High-Risk MDS

Lightning Reports™ from ASH 2022 on Low and High-Risk MDS

Talking Post-Transplant Acute Myeloid Leukemia - Improving Outcomes after Relapse: A CME Webcast Series*

Talking Post-Transplant Acute Myeloid Leukemia - Improving Outcomes after Relapse: A CME Webcast Series*

Case-Based Strategies to Integrate Recent Progress in Pulmonary Hypertension Due to Interstitial Lung Disease - Updated 11/16/2022

Case-Based Strategies to Integrate Recent Progress in Pulmonary Hypertension Due to Interstitial Lung Disease - Updated 11/16/2022

Current and Emerging Perspectives in Chronic Immune Thrombocytopenia - Updated 8/18/2022

Current and Emerging Perspectives in Chronic Immune Thrombocytopenia - Updated 8/18/2022

Case Studies in HAE: Diagnosing, Treating and Managing the Patient with Hereditary Angioedema - Updated 9/7/22

Case Studies in HAE: Diagnosing, Treating and Managing the Patient with Hereditary Angioedema - Updated 9/7/22

Clinical Viewpoints 2022 HAE Lecture Library

Clinical Viewpoints 2022 HAE Lecture Library

Diagnostic Considerations for Optimizing Successful Outcomes in Hemophagocytic Lymphohistiocytosis

Diagnostic Considerations for Optimizing Successful Outcomes in Hemophagocytic Lymphohistiocytosis

Hot Topics on Relapsed/Refractory Multiple Myeloma from the 63rd ASH Annual Meeting*

Hot Topics on Relapsed/Refractory Multiple Myeloma from the 63rd ASH Annual Meeting*

Hot Topics on CAR T- Cell Therapy from the 63rd ASH Annual Meeting*

Hot Topics on CAR T- Cell Therapy from the 63rd ASH Annual Meeting*

Hot Topics on Low-Risk Myelodysplastic Syndromes (MDS) from the 63rd ASH Annual Meeting*

Hot Topics on Low-Risk Myelodysplastic Syndromes (MDS) from the 63rd ASH Annual Meeting*

Emerging Therapy Approaches for High-Risk Myelodysplastic Syndromes (MDS) - Conversation 2 of 2

Emerging Therapy Approaches for High-Risk Myelodysplastic Syndromes (MDS) - Conversation 2 of 2

Updates in High-Risk Myelodysplastic Syndromes (MDS) - Conversation 1 of 2

Updates in High-Risk Myelodysplastic Syndromes (MDS) - Conversation 1 of 2

Conversations in Hematology/Oncology: Leukemic Transformation of Myelodysplastic Syndromes: Identification, Evaluation and Management Issues

Conversations in Hematology/Oncology: Leukemic Transformation of Myelodysplastic Syndromes: Identification, Evaluation and Management Issues

Independent Conference Coverage from the American College of Chest Physicians Annual Meeting 2021*

Independent Conference Coverage from the American College of Chest Physicians Annual Meeting 2021*

Independent Coverage of the 2021 International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress

Independent Coverage of the 2021 International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress

Independent Coverage of the 2021 European Hematology Association (EHA) Virtual Congress*

Independent Coverage of the 2021 European Hematology Association (EHA) Virtual Congress*

Case-Based Strategies to Improve Diagnosis and Treatment of PH-ILD - Updated 11/01/2021

Case-Based Strategies to Improve Diagnosis and Treatment of PH-ILD - Updated 11/01/2021

Conversations in Oncology: Updates in the Treatment of Graft Versus Host Disease

Conversations in Oncology: Updates in the Treatment of Graft Versus Host Disease

Emerging Considerations in the Management of PH-ILD - Updated 11/01/2021

Emerging Considerations in the Management of PH-ILD - Updated 11/01/2021